Ads
related to: tecfidera cost- GA Mechanism of Action
Learn More About How
Glatiramer Acetate Works
- View Savings and Support
Learn More About Patient Access
and Other Support Options
- GA Mechanism of Action
Search results
Biogen holds onto Tecfidera market in Europe for a little longer
BioPharma Dive via Yahoo Finance· 6 months agoA decision by European regulators to revoke approvals for five generic versions of Biogen's multiple...
Biogen Inc. (BIIB) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have lost about...
Why Is Biogen Inc. (BIIB) Up 2.6% Since Last Earnings Report?
Zacks via Yahoo Finance· 3 months agoIt has been about a month since the last earnings report for Biogen Inc. (BIIB). Shares have added...
Biogen (BIIB) Beats on Q2 Earnings & Sales, Ups 2022 Guidance
Zacks via Yahoo Finance· 2 years agoBiogen BIIB reported second-quarter 2022 earnings per share (EPS) of $5.25, which significantly beat...
Biogen's Turnaround Is Still Waiting In The Wings As Aduhelm Pressures Continue
Investor's Business Daily· 4 months agoBiogen's turnaround is still a "work in progress," an analyst said Tuesday as Biogen stock slumped...
Biogen tops 3Q expectations as cost cutting continues
Associated Press via Yahoo News· 2 years agoBiogen delivered a better-than-expected third quarter and hiked its 2022 forecast, as cost cutting...
Biogen (BIIB) Beats Q4 Earnings & Sales Estimates, Stock Up
Zacks via Yahoo Finance· 1 year agoBiogen BIIB reported fourth-quarter 2022 adjusted earnings per share (EPS) of $4.05, beating the...
Biogen fourth-quarter profit misses on Aduhelm exit costs
Reuters via AOL· 4 months agoLast month, Biogen said it will end a post-approval study of Aduhelm and return the licensing rights...
Biogen CEO bets on Alzheimer's drug, pipeline to return to growth
Reuters via Yahoo Finance· 1 year ago(Reuters) -Biogen Inc Chief Executive Officer Christopher Viehbacher said on Wednesday he is banking...
Biogen Skids On 'Low-Quality' Beat, Cuts Profit Guidance Following Reata Buyout
Investor's Business Daily· 7 months agoBiogen stock skidded Wednesday on a "low-quality" sales beat that relied on other revenue. But...
Ads
related to: tecfidera cost